Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gordon L Amidon

Showing results (21-30 of 185) with videos related to

Pageof 19
Sort By:
The AAPS Journal|March 26, 2009
The H2 receptor antagonist nizatidine is a P-glycoprotein substrate: characterization of its intestinal epithelial cell efflux transportArik Dahan, Hairat Sabit, Gordon L Amidon
Journal of Medicinal Chemistry|December 5, 2009
Enhancing the intestinal absorption of molecules containing the polar guanidino functionality: a double-targeted prodrug approachJing Sun, Arik Dahan, Gordon L Amidon
Biopharmaceutics & Drug Disposition|July 12, 2012
Mechanistic investigation of food effect on disintegration and dissolution of BCS class III compound solid formulations: the importance of viscosityAsma Radwan, Gordon L Amidon, Peter Langguth
Pharmaceuticals (Basel, Switzerland)|January 30, 2014
The dipeptide monoester prodrugs of floxuridine and gemcitabine-feasibility of orally administrable nucleoside analogsYasuhiro Tsume, Blanca Borras Bermejo, Gordon L Amidon
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|April 26, 2005
Pharmacokinetics of an immediate release, a controlled release and a two pulse dosage form in dogsRaimar Löbenberg, Jae Seung Kim, Gordon L Amidon
Molecular Pharmaceutics|July 26, 2008
Enhanced cancer cell growth inhibition by dipeptide prodrugs of floxuridine: increased transporter affinity and metabolic stabilityYasuhiro Tsume, John M Hilfinger, Gordon L Amidon
Pharmaceutical Research|June 15, 2011
Potential of amino acid/dipeptide monoester prodrugs of floxuridine in facilitating enhanced delivery of active drug to interior sites of tumors: a two-tier monolayer in vitro studyYasuhiro Tsume, John M Hilfinger, Gordon L Amidon
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|June 30, 2020
A proposed pediatric biopharmaceutical classification system for medications for chronic diseases in childrenVarsha Bhatt-Mehta, Hannah Hammoud, Gordon L Amidon
Expert Review of Clinical Immunology|July 3, 2010
Drug targeting strategies for the treatment of inflammatory bowel disease: a mechanistic updateArik Dahan, Gordon L Amidon, Ellen M Zimmermann
Drug Development and Industrial Pharmacy|November 25, 2005
Dissolution and solubility behavior of fenofibrate in sodium lauryl sulfate solutionsGladys E Granero, Chandrasekharan Ramachandran, Gordon L Amidon
Pageof 19

Showing results (21-30 of 185) with videos related to

Sort By:
Pageof 19
The AAPS Journal|March 26, 2009
The H2 receptor antagonist nizatidine is a P-glycoprotein substrate: characterization of its intestinal epithelial cell efflux transportArik Dahan, Hairat Sabit, Gordon L Amidon
Journal of Medicinal Chemistry|December 5, 2009
Enhancing the intestinal absorption of molecules containing the polar guanidino functionality: a double-targeted prodrug approachJing Sun, Arik Dahan, Gordon L Amidon
Biopharmaceutics & Drug Disposition|July 12, 2012
Mechanistic investigation of food effect on disintegration and dissolution of BCS class III compound solid formulations: the importance of viscosityAsma Radwan, Gordon L Amidon, Peter Langguth
Pharmaceuticals (Basel, Switzerland)|January 30, 2014
The dipeptide monoester prodrugs of floxuridine and gemcitabine-feasibility of orally administrable nucleoside analogsYasuhiro Tsume, Blanca Borras Bermejo, Gordon L Amidon
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|April 26, 2005
Pharmacokinetics of an immediate release, a controlled release and a two pulse dosage form in dogsRaimar Löbenberg, Jae Seung Kim, Gordon L Amidon
Molecular Pharmaceutics|July 26, 2008
Enhanced cancer cell growth inhibition by dipeptide prodrugs of floxuridine: increased transporter affinity and metabolic stabilityYasuhiro Tsume, John M Hilfinger, Gordon L Amidon
Pharmaceutical Research|June 15, 2011
Potential of amino acid/dipeptide monoester prodrugs of floxuridine in facilitating enhanced delivery of active drug to interior sites of tumors: a two-tier monolayer in vitro studyYasuhiro Tsume, John M Hilfinger, Gordon L Amidon
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|June 30, 2020
A proposed pediatric biopharmaceutical classification system for medications for chronic diseases in childrenVarsha Bhatt-Mehta, Hannah Hammoud, Gordon L Amidon
Expert Review of Clinical Immunology|July 3, 2010
Drug targeting strategies for the treatment of inflammatory bowel disease: a mechanistic updateArik Dahan, Gordon L Amidon, Ellen M Zimmermann
Drug Development and Industrial Pharmacy|November 25, 2005
Dissolution and solubility behavior of fenofibrate in sodium lauryl sulfate solutionsGladys E Granero, Chandrasekharan Ramachandran, Gordon L Amidon
Pageof 19